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Abstract
Background: Due to immunologic immaturity, IFN-c-producing T cell responses may be decreased in young children
compared to adults, thus we hypothesized that IFN-c responses to mycobacterial antigens in household contacts exposed
to Mycobacterium tuberculosis (Mtb) would be impaired in young children relative to adults. The objective of this study was
to compare whole blood IFN-c production in response to mycobacterial antigens between children and adults in Uganda.
Methodology/Principal Findings: We studied household contacts of persons with culture-positive pulmonary tuberculosis
(TB) enrolled in a cohort study conducted in Kampala, Uganda. Whole blood IFN-c production in response to Mtb culture-
filtrate antigens was measured by ELISA and compared between infants (,2 years old, n=80), young children (2 ,5 years
old, n=216), older children (5 ,15 years old, n=443) and adults ($15 years old, n=528). We evaluated the relationship
between IFN-c responses and the tuberculin skin test (TST), and between IFN-c responses and epidemiologic factors that
reflect exposure to Mtb, and the effect of prior BCG vaccination on IFN-c responses. Young household contacts
demonstrated robust IFN-c responses comparable to those of adults that were associated with TST and known risk factors
for infection. There was no effect of prior BCG immunization on the IFN-c response.
Conclusions/Significance: Young children in a TB endemic setting can mount robust IFN-c responses generally comparable to
thoseofadults,andasinadults,theseresponsescorrelatedwiththeTSTandknownepidemiologicriskfactorsforMtbinfection.
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Introduction
Pediatric tuberculosis represents a major cause of childhood
morbidity and mortality worldwide, affecting more than 800,000
children each year, and comprising approximately 10% of all cases
of TB [1]. Approximately 75% of childhood TB cases occur in
high burden countries with limited resources for health care.
Infants and young children are more likely than adults to develop
TB following infection with Mtb and disease is more likely to be
severe as reflected in the increase incidence of miliary TB and TB
meningitis [2]. The propensity for infants to develop severe TB
following infection is likely, at least in part, to reflect immunologic
immaturity.
Host defense to TB requires strong CD4
+ Th1 cell responses
[3]. Specifically, CD4
+ T cell responses are critical for contain-
ment of infection in the mouse TB model and individuals with
HIV infection in whom CD4
+ T cells are depleted are susceptible
to TB. CD4
+ Th1 cells are defined by production of IFN-c. In the
murine TB model, IFN-c is necessary for control of Mtb [3] and
rare humans with mutations in the IFN-c receptor are prone to
mycobacterial infection [4]. Young infants demonstrate dimin-
ished CD4
+ Th1 cell responses in response to pathogens compared
PLoS ONE | www.plosone.org 1 October 2008 | Volume 3 | Issue 10 | e3407to adults [5]. Therefore, we hypothesized that IFN-c production in
response to mycobacterial infection would be deficient compared
to those observed in older children and adults. To address this
hypothesis, we analyzed whole blood IFN-c responses to Mtb
antigens among household contacts of different ages in a setting of
high level Mtb transmission. This analysis represents the largest
study of IFN-c responses to Mtb antigens in young household
contacts of adult TB patients and the only direct comparison of
young children to older children and adults.
Results
A total of 2301 household contacts were enrolled in two
prospective cohorts accrued between October 1995 and April
2006. Three hundred individuals were eliminated from analysis
because of incomplete clinical and laboratory testing at baseline.
Of the remaining 2001 individuals, 961 individuals were enrolled
from 1995–1999 (Phase I, [6]) and 1040 individuals were enrolled
from 2002–2006 (Phase II, Figure 1). The two study populations
were similar with regard to demographic factors, and prevalence
of TB at enrollment, latent TB infection (LTBI), and HIV-infected
individuals. Of the total household contacts, 482 (281 in Phase I
and 201 in Phase II) were ,5 years old and 1519 (680 in Phase I
and 839 in Phase II) were $5 years old. Of total household
contacts, we excluded 132 contacts with TB and 188 contacts who
were HIV infected to obtain a total of 1681 healthy HIV
uninfected household contacts (410 contacts ,5 years old and
1271 contacts $5 years). Finally of these, 296 children ,5y e a r so l d
and 971 older children and adults had immunological data that
could be evaluated. The main reason that immunologic data was
unavailable was that after clinical testing there was insufficient blood
for immunological assays. More children ,5y e a r st h a n$5y e a r s
had missing immunologic data (27.7% vs. 23.6%, respectively,
p=0.089) reflecting the difficulties of obtaining blood from young
children.Sincethisstudycomparedimmuneresponsesofinfantsand
young children to those of older children and adults, $5m m( t h e
cut-off for a positive TST in household contacts ,5 years) was used
to define a positive TST throughout the analysis. A positive TST at
baseline, was more common among contacts $15 years or older,
than contacts ,15 years (85%vs. 67%, p,0.0001; Table1). A BCG
scar was identified more often in children younger than 15 years
than in older contacts (79% vs. 58%, p,0.0001).
Figure 1. Flow diagram depicting enrollment into two consecutive household contact studies. The numbers of individuals enrolled by
age, followed by elimination of individuals with TB, HIV infection, or inadequate blood specimens, resulting in the number of individuals evaluated by
IFN-c assays, are shown.
doi:10.1371/journal.pone.0003407.g001
Table 1. Baseline demographic and clinical characteristics of
healthy, HIV seronegative household contacts according to
age range.
,2 years
2 ,5
years
5 ,15
years $15 years P value
1
n=80 n=216 n=443 n=528
Female sex
2 42 (52.5%) 101 (46.8%) 239 (54.0%) 329 (62.3%) 0.001
TST $5m m
2 53 (66.2%) 140 (64.8%) 301 (68.0%) 449 (85.0%) ,0.0001
BCG scar
2 63 (78.8%) 172 (79.6%) 347 (78.3%) 295 (55.9%) ,0.0001
1Chi-square test for heterogeneity across groups.
2Numbers of subjects, followed by the percentages of subjects relative to the
total number of subjects in each age group in parentheses, are shown.
doi:10.1371/journal.pone.0003407.t001
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of all HIV negative household contacts at the time of study
enrollment were similar in all age groups (Figure 2). The median
log10 IFN-c responses ranged from 2.80 among infants ,2 years to
3.06 among adults. The responses were higher in household
contacts $15 years old than infants (,2 years; p=0.015), but the
differences in medians among groups were small (less than 0.3 log
units) and unlikely to be biologically significant. Even the youngest
household contacts mounted IFN-c responses comparable to older
children and adults. There were no other statistically significant
differences seen among age groups.
To further analyze the magnitude of the IFN-c response across
age groups, we studied the proportion of positive IFN-c assays in
comparison to the proportion of positive TSTs between different
age groups. Specifically, we analyzed the concordance between
IFN-c assay results and TST results in young children (,5 years)
compared to older children and adults ($5 years, Table 2).
Concordance between the IFN-c response and the TST was
statistically significant for both age groups (,5 years, k=0.397;
$5 years, k=0.394; p,0.0001). Concordance rates between
whole blood IFN-c assay and TST results were similar in young
children and older children and adults (p=0.554).
To compare the relationship of the TST to IFN-c responses, we
compared the magnitude of IFN-c responses between TST
positive and TST negative individuals within each age group of
healthy household contacts (Figure 3). Furthermore, to evaluate
the effect of prior BCG vaccination on IFN-c responses, we
analyzed household contacts without a history of prior BCG
vaccination (Figure 3A) separately from household contacts with a
history of prior BCG vaccination (Figure 3B). Among BCG
unimmunized individuals (Figure 3A), there were no significant
differences in median IFN-c assay results among age groups of
TST negative individuals. However, within each age group,
median IFN-c responses of TST positive individuals were
consistently higher than those of TST negative individuals and
for all age groups except for the ,2 year olds, the differences were
statistically significant (,2 years, p=0.281; 2 ,5 years, p=0.002;
5 ,15 years, p,0.0005; and $15 years, p,0.0005). Among BCG
vaccinated individuals, median IFN-c responses of TST positive
individuals were higher than those of TST negative individuals
and for all age groups the differences were statistically significant
(,2 years, p,0.001; 2 ,5 years, ,0.0005; 5 ,15 years,
p,0.0005; and $15 years, p,0.0005). Furthermore, using a
linear regression model, which includes age, BCG, and TST
result, the only significant predictor of log10 IFN-c was TST status
(TST, p,0.0005; BCG, p=0.144; age, p=0.161). These data
suggest that the magnitude of the IFN-c whole blood response
correlates with TST in young children as it does in adults.
Moreover, BCG vaccination does not appear to affect median
IFN-c responses.
Finally, we examined the relationship between IFN-c responses
and established risk factors that reflect exposure to Mtb. Among
children ,5 years old, cavitary disease, sputum acid fast bacillus
(AFB) grade, and extent of disease on chest x-ray in the index case
were associated with higher IFN-c responses (data not shown,
p,0.05). Similarly, among contacts $5 years old, IFN-c responses
were associated with cavitary disease and higher smear grade in
the index case (p,0.05). As for household characteristics,
crowding and sharing a bed were associated with higher IFN-c
responses among contacts $5 years old, but not in younger
children (p,0.05). In general, IFN-c levels were consistently
higher for risk factors reflecting greater exposure to the index case.
Discussion
In general, in response to infectious pathogens and vaccines, the
T cell response of young children may demonstrate decreased
magnitude and slower kinetics than that observed in older children
and adults, and it is more likely to represent TH2-type T cell
immunity [5]. More specifically regarding Mtb antigens, Kamp-
mann and colleagues showed that IFN-c production in response to
Mtb antigens was lower in young children (,5 years old) than in
older children (5–15 years old) [7]. However in this cohort of
household contacts of culture-positive pulmonary tuberculosis
patients from a TB endemic area, we observed that young children
mounted robust IFN-c responses generally comparable to adults.
Our study provides the first direct comparison of adults and
children from the same household contact setting. Moreover,
adequate numbers of individuals of various ages were enrolled to
allow statistically robust comparisons. Therefore, we conclude that
in these healthy young children from a TB endemic area, who do
not develop active TB following household exposure to Mtb,
Figure 2. Comparison of whole blood IFN-c responses to Mtb
antigens for different age groups. Boxplots illustrate the median
and distribution of log10-transformed IFN-c results by age group (,2, 2
,5, 5 ,15, and $15 years).
doi:10.1371/journal.pone.0003407.g002
Table 2. Concordance between IFN- c assay and TST result by
age of contacts.
Age group
,5 years $5 years
IFNc+/TST+ 146 (49.3%) 612 (63%)
IFNc+/TST2 36 (12.2%) 86 (8.9%)
IFNc2/TST+ 47 (15.9%) 138 (14.2%)
IFNc2/TST2 67 (22.6%) 135 (13.9%)
IFNc+ rate 0.615 0.719
TST+ rate 0.652 0.772
Concordance rate 0.720 0.769
k coefficient
1, (SE) 0.397 (0.055) 0.394 (0.033)
TST=Tuberculin skin test; IFNc=results of the whole blood IFN-c assay for Mtb
antigen; SE=Standard error.
1p,0.0001 for concordance between TST and
IFNc.
doi:10.1371/journal.pone.0003407.t002
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c responses to Mtb antigens.
Prompt, accurate identification of infants and young children
with Mtb infection is an important priority as they are at higher
risk of progression to disease and of developing more severe
disease than older children and adults [2]. Until recently, diagnosis
of LTBI has relied on the tuberculin skin test (TST). However,
development of interferon-gamma (IFN-c) release assays (IGRAs)
offer new ways to make the diagnosis of LTBI. One type of IGRA
is the whole blood assay, which detects Mtb-antigen induced IFN-
c expression by T cells in whole blood using an ELISA
(QuantiFERONH-TB Gold and QuantiFERONH- Gold IT
[Cellestis, Corp]). A second type of IGRA is based on the
ELISPOT assay which detects the frequency of IFN-c secreting
cells in response to Mtb antigens (T-spot.TB test [Oxford
Immunotec, Inc.]). Although these assays are technical and
expensive, there is interest in developing them further for use in
resource-limited settings where TB is endemic. The usefulness of
IGRAs in making the diagnosis of Mtb infection in children is not
yet firmly established and whether or not age itself, due to a
decreased capacity to produce IFN-c, decreases the sensitivity of
IGRAs remains controversial. For example, the QuantiFERONH-
TB demonstrated poor sensitivity for diagnosis of LTBI in
Australian children, and negative results correlated with young
age [8]. Furthermore, a study of IGRAs in a diverse clinical
population showed that indeterminate results of the Quanti-
FERON Gold test were disproportionately high in children less
than 5 years of age [9]. However, one study of South African
children, found that ELISPOT was more sensitive than TST in
diagnosing Mtb infection with children ,3 years of with probable
or confirmed TB [10] and a study of European children showed
that both QuantiFERON Gold and T-spot.TB were as sensitive as
TST in detecting Mtb infection in children with culture confirmed
TB [11]. One implication of our results for the potential utility of
IGRAs in children is that the results of this large study of
household contacts from a TB endemic, where the immune
responses of children of all ages and adults were directly
compared, indicates that IFN-c responses in healthy individuals
were equivalent and robust, and hence the sensitivity of IGRAs
should not be compromised by young age alone.
IFN-c responses in young children, as in adults, correlated with
the TST and known risk factors for infection. Our results are
consistent with those from child household contact studies using an
ELISPOT assay [12,13] or a whole blood assay [14,15] where
IFN-c responses were also correlated with TST results and risk
factors for infection. The concordance rates between commercial
IGRAs and TST have been studied in several studies of children
and vary widely from concordance rates of 26% to 95% (k
coefficients=0.08–0.73) depending upon the clinical setting
[8,11,14–18]. We found a concordance rate (72%) which falls
within this broad range. Moreover, in our study, we directly
compare concordance between young children and adults in the
household contact setting and found them to be similar.
Our analysis of children enrolled in the first two years of the first
household contact study [19] as well as the current analysis of
children enrolled over both studies presented here suggest that, in
a setting of high exposure to Mtb within an endemic community,
prior BCG vaccination does not affect TST results. Moreover, we
conclude that prior BCG vaccination does not affect IFN-c results.
This is different than the results of Soysal et al [12] who reported
that their in-house IFN-c ELISPOT assay was negative more
often in BCG immunized than in unimmunized children. It is
possible that differences in methodology could account for the
discrepancy in the results between these two studies in that in the
Soysal et al study, an ELISPOT assay using short-term overnight
incubation and Mtb specific antigens, ESAT-6 and CFP-10 were
used while in our study a longer term (5–7 day) whole blood assay
with Mtb culture filtrate antigens were used.
Figure 3. (a) Comparison of whole blood IFN-c assay results by age and TST status in BCG unimmunized individuals. Boxplots that
illustrate the median and distribution of log10-transformed IFN-c results of BCG unimmunized household contacts are shown. Comparisons between
age groups are shown. Additionally, within each age group, comparisons between TST positive and TST negative are shown. Numbers of individuals
in each subgroups is as follows: ,2, TST negative, 8; ,2, TST positive, 9; 2 ,5, TST negative, 18; 2 ,5, TST positive, 26; 5 ,15, TST negative, 29; 5
,15, TST positive, 67; $15, TST negative, 37; $15, TST positive, 146. (b) Comparison of whole blood IFN-c assay results by age and TST
status in BCG immunized individuals. Boxplots that illustrate the median and distribution of log10-transformed IFN-c results of BCG immunized
household contacts are shown. Comparisons between age groups are shown. Additionally, within each age group, comparisons between TST
positive and TST negative are shown. Numbers of individuals in each subgroups is as follows: ,2, TST negative, 19; ,2, TST positive, 44; 2 ,5, TST
negative, 58; 2 ,5, TST positive, 114; 5 ,15, TST negative, 113; 5 ,15, TST positive, 234; $15, TST negative, 42; $15, TST positive, 253.
doi:10.1371/journal.pone.0003407.g003
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household contacts should not be extrapolated to young children
immunocompromised by conditions other than age such as HIV.
Future studies, including those using commercially available
IGRAs, should continue to elucidate the interaction between the
young host, Mtb and distinct immunocompromising conditions. In
addition, while young children are capable of mounting strong
IFN-c responses to Mtb antigens, it remains to be determined
whether or not difference in other aspects of the T cell response to
Mtb could predispose children to development of active TB, such
as excessive Th2, Th17, and/or T regulatory responses and/or
deficient CD8
+ T cell responses. Alternatively, perhaps differences
in innate, rather than adaptive immunity could be responsible for
these differences in disease susceptibility, all areas which will
require addition study.
Materials and Methods
Patients and inclusion criteria
This study was performed in healthy, HIV seronegative
household contacts of adult pulmonary TB cases enrolled in one
of two prospective cohorts accrued between October 1995 and
April 2006 in Kampala, Uganda [6,20]. The enrollment criteria
for the two cohorts were similar except that the earlier cohort
enrolled only smear positive adult pulmonary TB cases whereas
the second cohort enrolled culture positive TB index cases that
could be sputum smear negative or positive.
Subjects were enrolled after institutional review board approval
was secured at both University Hospitals Case Medical Center in
Cleveland and the Uganda Council for Science and Technology in
Uganda, and written informed consent was obtained from the
head of the household and all individuals within the household. At
baseline, evaluation for active TB was performed in all household
contacts with symptoms consistent with TB and in all children less
than 5 years of age whether symptomatic or not. All subjects were
followed prospectively for two years and evaluation for active TB
was repeated in all individuals who developed symptoms consistent
with TB during this time. Evaluation included a medical
examination, sputum microscopy, mycobacterial culture of
sputum and for children, gastric aspirates, and chest radiograph.
HIV testing was performed after consent and counseling using
enzyme-linked immunosorbent assay. For children, HIV testing
was done on symptomatic children ,10 years old and healthy
children ,2 years old born to HIV seropositive women, otherwise
the child was considered to be HIV seronegative. For children
#18 months old with a HIV seropositive mother, HIV was
excluded by HIV DNA PCR when available. Vaccination with
BCG was determined by the presence of a scar on the left deltoid
and verified using medical records when possible. TST was
performed at baseline on all household contacts and starting in
2002, was performed serially on TST negative individuals using
purified protein derivative (PPD, 5 TU, Tubersol; Connaught
Laboratories, Limited, Toronto, Canada) and the Mantoux
method. A positive TST was defined as $5 mm in children ,5
years of age and in HIV infected individuals and was defined
$10 mm in HIV uninfected individuals $5 years of age. All
subjects ,5 years old and all HIV infected subjects in whom active
TB was ruled out received preventive therapy with isoniazid (INH)
regardless of TST result. Starting in 2002, HIV uninfected
individuals $5 years of age with a positive TST at baseline or who
converted their TST from negative to positive during the two year
follow-up period were offered preventive therapy with INH. LTBI
treatment decisions were based solely on age, HIV serology and
TST criteria.
From all enrolled household contacts with baseline clinical,
HIV, and TST evaluation, individuals with TB at baseline or who
developed TB at any point during the two year follow-up,
individuals in whom HIV testing was positive or not performed,
and individuals without immunologic data at baseline were
removed from the analysis, as shown in Figure 1. The resulting
study group comprised household contacts who were HIV
seronegative, had active TB ruled out through clinical and
laboratory evaluation, and had a whole blood IFN-c assay
performed at the time of enrollment. Groups for analysis were
defined by age (,2 years; 2 ,5 years; 5 ,15 years; and $5 years
or older) which were based on observed risk of disease (,5 years)
and increased severity of disease (,2 years) in household contacts
of infectious tuberculosis cases [1,6]. For this analysis, adults were
defined as individuals 15 years of age or older. TST results
reported herein were those obtained from the TST placed at
enrollment.
IFN-c release assay
For all data reported herein, a whole blood IFN-c assay was
performed at baseline. Whole blood was collected via venipunc-
ture prior to the placement of the TST and placed in a
heparinized tube. Within four hours, whole blood was diluted
1:10 with RPMI 1640 and cultured in 48-well tissue culture plates
(1 ml/well) with or without Mtb culture filtrate (10 mg/ml) and
incubated at 37u for 5–7 days at which point supernatants from
cultured cells were collected and cryopreserved (270uC) for batch
testing by ELISA. IFN-c concentration (pg/ml) in culture
supernatants was determined with a commercial ELISA (Endogen,
Rockford, IL) in duplicate wells according to the manufacturer’s
instructions. We defined a positive IFN-c assay as exceeding
304 pg/ml. This cut-off value was derived as the sum of the mean
plus two standard deviations derived from all the media wells. For
assays performed on subjects enrolled in the first cohort, no PHA
control was included. For assays performed on subjects enrolled in
the second cohort, a PHA control (5 mg/ml) was included. Mtb
culture filtrate was obtained from the TB Vaccine Testing and
Research Materials Contract (HHSN266200400091C, NIH,
NIAID, P.I., John Belisle) or from Robert Wallis (UMDNJ-New
Jersey Medical School, Newark, NJ) and prepared as described
(http://www.cvmbs.colostate.edu/microbiology/tb/mixculture-
filp.htm). Briefly, Mtb was grown to late-log phase in glycerol-
alanine-salts medium. The culture supernatant was filtered,
concentrated by ultrafiltration, and dialyzed against 0.01 M
ammonium bicarbonate.
Statistics
Comparisons of demographic and clinical characteristics
according to age range were performed using a chi-square test
for heterogeneity across groups. For results of whole blood IFN-c
assays, IFN-c levels were transformed using the logarithm base-10
(log10) to reduce variance in distributions. As PHA positive control
data was limited to whole blood assays performed on participants
in the second cohort, we performed a preliminary analysis to
estimate the percentage of assays in which viable functional cells
were tested, i.e. interpretable assays. Specifically, an interpretable
assay was defined as one in which either the response to Mtb
antigen was positive (as defined below) or the PHA response was
positive (.50 pg/ml). Using these criteria, 544 of 570 (95%) of all
assays in which the PHA control was performed were interpret-
able. In addition, the proportion of un-interpretable assays was not
statistically significantly different between individuals ,5 years
and those $5 years (7.2% versus 3.9%, p=0.159). Therefore, we
chose to include all available whole blood assay results on all
Immunity in TB Exposed Young
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was included in the assay. For comparisons of IFN-c as a
continuous variable, non-parametric methods (Mann-Whitney
test) were used for comparisons because the distribution of
cytokine levels was not normal, even after logarithm transforma-
tion. To assess the combined effects of age, TST status, and BCG
vaccination on log-transformed IFN-c, we conducted a regression
analysis, utilizing a George-Elston transformation to allow for the
non-normality of the data [21]. To assess the concordance
between the TST and our IFN-c assay, we determined the
percentage of individuals in each category (positive TST/positive
IFN-c, positive TST/negative IFN-c, negative TST/positive IFN-
c, negative TST/negative IFN-c), stratified by age. The
concordance rate was determined from individuals positive for
both plus those negative for both divided by the total, and the
discordance rate was the complement of the concordance rate. A
kappa (k) statistic was estimated to illustrate the agreement
between the two tests, and a significant p-value indicates that the
agreement between the two tests was not due simply to chance.
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